Skip to main content
Clinical Trials/NL-OMON27031
NL-OMON27031
Recruiting
N/A

Towards a minimally invasive approach of atypical lipomatous tumors: the MINIMALIST trial

Erasmus MC Cancer Institute0 sites238 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
-Atypical lipomatous tumor-Well-differentiatied liposarcoma-Lipoma
Sponsor
Erasmus MC Cancer Institute
Enrollment
238
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Erasmus MC Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Aged \=18 years
  • \-Primary or recurrent lipomatous tumor suspected for lipoma or atypical lipomatous tumor
  • \-Adequate understanding of the Dutch or English language (to fill out the HRQoL questionnaires)

Exclusion Criteria

  • \-Tumor localization in the mediastinum, retroperitoneum or testis/scrotum
  • \-Diagnosis through excisional biopsy
  • \-Any type of treatment for the current tumor (i.e. in case of recurrence, treatment of the prior tumor(s) is allowed)
  • \-Signs/suspicion of dedifferentiation in the biopsy specimen at time of diagnosis
  • \-Unable to undergo regular MRI\-scans (for example because of a pacemaker, claustrophobia)
  • \-Systemic treatment for any other concurrent malignancy
  • \-Currently receiving radiotherapy at affected site for other concurrent disease
  • \-Incapable to understand the study, to sign informed consent or to fill out the HRQoL\-questionnaires

Outcomes

Primary Outcomes

Not specified

Similar Trials